Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Using a mobile app to track pain in musculoskeletal disease patients

Official title: The Importance of Ecological Momentary Assessment to Capture the Whole Patient's Symptoms Experience in Musculo-skeletal Conditions

Run by Ente Ospedaliero Cantonale, Bellinzona · NCT06283199 · Data updated 2026-11-12

This study tests whether using a mobile app to track pain and daily activities can help people with musculoskeletal diseases understand their symptoms better.

More Musculoskeletal Pain trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorEnte Ospedaliero Cantonale, Bellinzona
Academic / other
Locations2 sites (Bologna and 1 other locations)
StatusRecruiting
StartedApril 6, 2021
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 11, 2026
Trial IDNCT06283199 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are symptomatic adults over 18 years old who can use a smartphone and have a confirmed diagnosis of musculoskeletal disease.

Probably not a fit

Patients without symptoms of musculoskeletal injury or those with other diseases causing joint pain may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves patients using a mobile application to record their pain and functional status twice daily over a two-month period. Patients will also attend follow-up visits after one month and at the end of the two months to retrospectively assess their pain and function from the previous month. The goal is to compare real-time pain reports with retrospective evaluations to better understand symptom patterns in musculoskeletal diseases.

Why it matters

Potential benefit: If successful, this approach could lead to more accurate assessments of pain and function in patients with musculoskeletal diseases, improving treatment strategies.

How similar studies have gone: While the use of mobile applications for symptom tracking is gaining traction, this specific approach of comparing real-time and retrospective assessments is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Symptomatic patients
* Patients able to give informed consent and to follow the protocol of the study (i.e. able to use a smartphone)
* Patients \>18 years
* BMI \<35 and \>18.5
* Patients with a smartphone with Android or iOS as operative systems

Exclusion Criteria:

* Patients unable to follow the protocol of the study (i.e. unable to use a smartphone, not owning a smartphone or unwilling to download or use the application)
* Patients with a diagnosis of a musculoskeletal injury but without symptoms
* Patients without a radiological examination confirming the diagnosis of musculoskeletal disease
* Patients with planned surgery in the following 60 days
* Pregnant or lactating woman
* Patients with other diseases causing pain in the involved joint (e.g. rheumatoid arthritis or other rheumatologic diseases).
* Surgical treatment in the last year and intra-articular injection in the last 6 months

Where it's running

  • IRCCS Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting
  • EOC - Orthopaedics and Traumatology Service
    Lugano, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.